Compositions and methods for the treatment of angiogenesis-related eye diseases

Details for Australian Patent Application No. 2010336475 (hide)

Owner DCB-USA LLC National Cheng Kung University National Taiwan University TWI Biotechnology, Inc.

Inventors Chuang, Woei-Jer; Fu, Wen-Mei; Huang, Yen-Lun

Agent Spruson & Ferguson

Pub. Number AU-A-2010336475

PCT Pub. Number WO2011/079175

Priority 61/289,624 23.12.09 US

Filing date 22 December 2010

Wipo publication date 30 June 2011

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/079175 Priority application(s): WO2011/079175

20 September 2012 Assignment before Grant

  National Taiwan University; TWI Biotechnology, Inc.; DCB-USA LLC; National Cheng Kung University The application has been assigned to National Cheng Kung University; National Taiwan University Assignments before Grant, Section 113 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010336485-Anti-bv8 antibodies and uses thereof

2010336467-Oral care compositions